PREVAIL trial

Medivation Reports Third Quarter 2010 Financial Results and Provides Corporate Update
Yahoo/PR NewsWire
Sat, 11/6/10 - 12:51 pm
Medivation
MDV3100
prostate cancer
PREVAIL trial